Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by Wide Margin YALA Q1 2026 Earnings Positive EPS of 016 Drives Modest Share Uptick COUR Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Positive Outlook ADT Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Decline IGC Pharma Q1 2026 Earnings Narrower Loss Beats Estimates Shares Edge Lower AMCX Q1 2026 Earnings EPS Misses Estimates Sharply as Stock Rises 37